Literature DB >> 2779617

The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.

J W Ward1, T J Bush, H A Perkins, L E Lieb, J R Allen, D Goldfinger, S M Samson, S H Pepkowitz, L P Fernando, P V Holland.   

Abstract

Patients infected by the human immunodeficiency virus (HIV) as a result of blood transfusions are unique in that their dates of infection are well defined and their medical conditions before infection are known. To characterize the natural history of transfusion-associated HIV infection, we studied 694 recipients of blood from 112 donors in whom AIDS later developed and from 31 donors later found to be positive for HIV antibody. Of the recipients tested, 85 were seronegative, 116 were seropositive, and 19 had AIDS. Of 101 HIV-seropositive recipients followed for a median of 55 months after infection, 54 had Centers for Disease Control Class IV disease, including 43 with AIDS. Life-table analysis suggested that AIDS will develop in 49 percent of infected recipients (95 percent confidence limits, 36 to 62 percent) within seven years after infection. As compared with recipients without AIDS, the 43 recipients with AIDS had received more transfusions at the time of infection (median, 21 vs. 7; P = 0.01). HIV-infected blood donors in whom AIDS developed were grouped according to whether AIDS developed within 29 months (the median) after donation (Group 1) or 29 or more months after donation (Group 2). As compared with the 31 recipients of blood from Group 2 blood donors, the 31 recipients of blood from Group 1 donors were more likely to have AIDS four years after infection (49 percent vs. 4 percent; P = 0.005) and illnesses resembling acute retroviral syndrome (14 of 24 vs. 5 of 22; P = 0.03). We conclude that most recipients of HIV-infected blood become seropositive, that AIDS develops in about half these recipients within seven years, and that the risk may be higher when AIDS develops in the blood donor soon after donation.

Entities:  

Mesh:

Year:  1989        PMID: 2779617     DOI: 10.1056/NEJM198910053211406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  33 in total

1.  Altruism in surgery of AIDS patients.

Authors:  Lawrence A Pottenger; Homer U Ashby; Carolyn R Thompson
Journal:  J Relig Health       Date:  1992

2.  Costs of epoetin in patients with AIDS.

Authors:  D H Henry
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

3.  Circumstances at HIV diagnosis and progression of disease in older HIV-infected Americans.

Authors:  D S Zingmond; N S Wenger; S Crystal; G F Joyce; H Liu; U Sambamoorthi; L A Lillard; A A Leibowitz; M F Shapiro; S A Bozzette
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

4.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

5.  Human immunodeficiency virus infection in children who received transfusions in Mexico.

Authors:  R M Ferdman; J A Church; L Mascola; J K Sato
Journal:  West J Med       Date:  1991-11

6.  A meta-analysis of estimates of the AIDS incubation distribution.

Authors:  P C Cooley; L E Myers; D N Hamill
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

7.  The UK register of HIV seroconverters: methods and analytical issues. UK register of HIV seroconverters (UKRHS) Steering Committee.

Authors: 
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

Review 8.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

Review 9.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

10.  Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.

Authors:  C A Lee; A N Phillips; J Elford; G Janossy; P Griffiths; P Kernoff
Journal:  BMJ       Date:  1991-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.